Perspective Therapeutics (CATX) Q3 2024 Earnings
CATX·Reported November 12, 2024·Before market open
Perspective Therapeutics reported Q3 2024 revenue of $369.0K, beat analyst consensus of $292.8K by $76.2K. Diluted EPS came in at $-0.21.
Revenue
$369.0Kbeat by $76.2K
Consensus: $292.8KDiluted EPS
$-0.21met estimate
Consensus: $-0.21
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Perspective Therapeutics's Q3 2024 earnings report.
Perspective Therapeutics (CATX) reported Q3 2024 earnings on November 12, 2024 before market open.
Perspective Therapeutics reported revenue of $369.0K and diluted EPS of $-0.21 for Q3 2024.
Revenue beat the consensus estimate of $292.8K by $76.2K. EPS beat the consensus estimate of $-0.21 by $0.00.
You can read the 10-Q periodic report (0000950170-24-125399) directly on SEC EDGAR. The filing index links above go to sec.gov.